Get started
Author

Ahmed N. Absi

BU- vs TBI-based conditioning for adult patients with ALL
2010 · M Kalaycio, B Bolwell, et al. · Bone Marrow Transplantation · 26
Analysis of Patient-Physician Concordance in the Understanding of Chemotherapy Treatment Plans Among Patients With Cancer
2020 · Hani Almalki, Ahmed Absi, et al. · JAMA Network Open · 22
PDF
Response to imatinib therapy in adult patients with chronic myeloid leukemia in Saudi population: a single-center study
2014 · Enaam Alsobhi, Mohammed Burhan Abrar, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 11
Early infection in post-autologous hematopoietic stem cell transplant patients
2021 · Roaa S. Gassas, Ahmed N. Absi, et al. · Saudi Medical Journal · 5
PDF
Real-World Evidence Assessing the Safety of Administering Intravenous Rituximab Biosimilar in the First Cycle and Subcutaneous Rituximab in Subsequent Cycles in B-Cell Lymphoma Patients
2025 · Tamather Almandeel, Mansoor Ahmed Khan, et al. · Pharmacy · 1
PDF
ALL-287 T Cells Under the Influence of Blinatumomab Masquerading as Blasts
2023 · Fajer Alsejari, Fatma Khadadah, et al. · Clinical Lymphoma Myeloma & Leukemia · 1
PDF
Hyperferritinemia with iron deposition in the basal ganglia and tremor as the initial manifestation of follicular lymphoma
2021 · Hussein Algahtani, Ahmed Absi, et al. · International Journal of Neuroscience · 1
10 Comparing antifungal prophylaxis efficacy between fluconazole and amphotericin B lipid complex in adult patients with acute lymphocytic leukemia (ALL) receiving hyper-CVAD-based chemotherapy
2019 · Afnan Yousef Alamri, Mansoor Ahmed Khan, et al. · Abstracts · 1
PDF
Real-world (RW) use of fixed-duration (FD) ibrutinib+venetoclax (Ibr+Ven) in patients (pts) with previously untreated chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): Pooled analysis of REALITY-worldwide (WW) and REALITY-2 prospective cohort studies
2025 · Catherine Thieblemont, Emmanuelle Tchernonog, et al. · Blood
PDF
Evaluation of Efficacy and Safety of Nivolumab in Treatment of Relapsed/Refractory Classical Hodgkin Lymphoma at King Abdulaziz Medical City-Jeddah/the Kingdom of Saudi Arabia Experience
2023 · Amani Reda Alsafi, Majed Alahmadi, et al. · Blood
PDF
Real-World Use of Hypomethylating Agents (HMA)/Venetoclax Combinations in Patients with Myelodysplastic Neoplasms (MDS) in the Arabian Gulf Region
2023 · Fatima Khadadah, Honar Cherif, et al. · Blood
PDF
334MO A multicenter retrospective study to understand the clinical characteristics, treatment patterns, and outcomes of CLL patients in the Middle East: A subgroup analysis of the CREEK study
2023 · R.M. Abdelfattah Soliman, A. Alhuraiji, et al. · Annals of Oncology
PDF
The Role of Pre-bone Marrow Transplantation Pulmonary Function Test in Predicting Post-transplant Noninfectious Pulmonary Complications
2023 · Amani S. Ahmed, Roaa S. Gassas, et al. · Saudi Journal of Medicine and Medical Sciences
A Multicenter Retrospective Study to Understand the Clinical Characteristics for Patients With Chronic Lymphocytic Leukemia: Interim Results From the Creek Study
2023 · A. Al‐Huraiji, R. M. Soliman, et al. · Hematological Oncology
PDF
Outcome of 62 Patients with Burkitt Lymphoma: Local Experience from Princess Noorah Oncology Center – King Abdulaziz Medical City – Jeddah – Saudi Arabia from 2000 to 2017
2019 · Amani Ahmed, Ahmed Alsaeed, et al. · Clinical Lymphoma Myeloma & Leukemia
Brentuximab Vedotin Plus Bendamustine: As Salvage Regimen for Relapsed or Refractory Hodgkin Lymphoma, King Abdulaziz Medical City–Jeddah–KSA Experience
2019 · Muteb Althomali, Ahmed Absi, et al. · Clinical Lymphoma Myeloma & Leukemia
Retrospective Analysis of Patient Characteristics and Treatment Outcomes of Patients with Chronic Lymphocytic Leukemia Treated at Princess Noorah Oncology Center – King Abdulaziz Medical City – Jeddah – Saudi Arabia from 2000 to 2016
2018 · Muna Adam, Ahmad Alsaeed, et al. · Clinical Lymphoma Myeloma & Leukemia
Works count: 17
Citation count: 68
H-index: 4
I10-index: 3
Year
Topic
Type